LONDON: The US government is close to a deal to fund Moderna’s late-stage mRNA pandemic vaccine trial Bird Flu VaccineThe financial Times on Thursday, as per the report H5N1 outbreak The disease spreads on egg farms and among cattle.

Federal funding Biomedical Advanced Research And development Authority The (BARDA) approval could come as soon as next month, the report said, and would include a promise to purchase doses if Phase 3 trials are successful.

According to the report, the total cost is expected to be several hundred million dollars, and could also include a commitment to purchase doses if Phase III trials are successful.

Moderna and US Department of Health and Human Services (HHS) did not immediately respond to Reuters requests for comment.

In the United States, Canada and Europe CSL is in active talks with companies such as Seqirus and GSK to acquire or form serogroups. H5N1 Bird Flu VaccinesWhich can be used to protect vulnerable poultry and dairy workers, veterinarians and laboratory technicians.

Last week, a second human case of bird flu was confirmed in the United States, while the virus was first detected in dairy cattle in late March.

Bird flu has raised concerns because the disease spreads rapidly among mammals, with the first outbreak detected in dairy cows in the United States raising concerns it could spread to humans through the country’s milk supply.

So far in 2022, bird flu has infected more than 90 million chickens, 9,000 wild birds, 52 dairy herds and three people in the country.

(Reporting by Kanjik Ghosh; Editing: Savio D’Souza and Sherry Jacob-Phillips)